How to Benefit from Canada’s Upcoming Legal Marijuana Boom?

Legal Marijuana Canada
Source: INC

Those interested in investing in the legal cannabis industry can look for the U.S companies offering an opportunity. However, as marijuana remains illegal at a federal level, there is a risk for these companies. A large number of investors have, instead, opted to shift their attention to Canada which has a federally legal marijuana program and is expected to become the first nation with legal cannabis access for adults. Apart from the ability to serve its population, the Canadian cannabis industry has a large number of licensed producers involved actively in international markets such as Latin America, Europe, Israel and Australia. Such companies don’t just export but also prepare to acquire a license for the cannabis cultivation along with local investors. One of the most exciting markets for Cannabis Investment, Germany is engaged in distribution through existing pharmacies. 

Health Canada is responsible for the licensing and regulation of the Canadian marijuana industry and it has granted about 90 licenses some of which are given to companies with multiple licenses. About 28 companies trade on the Canadian Securities Exchange, TSX Venture Exchange or Toronto Stock Exchange. Many of them are listed on the OTC as well as U.S listings. 15 of these companies could raise selling securities amounting to 1.17 billion CAD. The access to capital is what makes the difference between the U.S and the Canadian marijuana companies. An index for those interested in cannabis investment gives an idea of the performance of the sector. The top tier of the index consists of the biggest producers and it includes six companies generating annual sales exceeding 16 million CAD. Tier 2 includes those that generate sales but not at the same scale as the leading ones and tier 3 are the companies which have acquired the license to cultivate weed but aren’t yet permitted to sell. Overall, the sector has performed well over the last two years. 

The top tier includes companies like Aphria, Aurora Cannabis, MedReleaf, Canopy Growth and CannTrust Holdings. U.S. investors willing to buy Canadian producers can open an account which allows trading Canadian securities but also makes it possible to buy the U.S. listings. Another alternative for Cannabis Investment is exchange-traded funds or ETFs. Canadian LPs currently comprise over 80 percent of the holdings of the Horizons Marijuana Life Sciences Index ETF. The decline in prices has not affected the valuations of Canadian LPs. Future sales are expected to increase with the legalization. Aurora Cannabis and Canopy Growth have market caps of about 6 billion CAD while Aphria has 2.8 billion CAD, MedReleaf 1.9 billion CAD, CanniMed 882 million CAD and CannTrust has a cap of 793 million CAD. The caps of the U.S. market are close to 20 percent lower than the Canadian cannabis industry. 

Conclusion

Canadian marijuana companies are safer investment options than those in the U.S as it is federally legal and have performed quite well. The psychedelics industry has arrived, and its quickly gaining attention from investors, the emerging sector gained global media attention as two new psychedelic stocks went public. Magic Mushrooms Canada could be the next investment trend as it have a long lasting positive effect on emotional health.

Vaping and E-Cigarette Ads Soon Coming to Television, Newspaper or Radio Near You

Weed Acessories
Source: Business Insider

The newly introduced Tobacco and Vaping Products Act by the federal government forces tobacco companies to switch to plain packaging. However, this act opens up an entirely new world of advertising possibilities for e-cigarettes and vaping liquids. 

The latest law which has received a lot of royal assents as it was introduced, regulates and legalizes something that we knew by ‘bold, black market’. It gives Canada the power it needs to use plain packaging for tobacco products. 

Though illegal, vaporizing liquid containing nicotine was sold at numerous vape shops and even in weed Canada stores, in cities across the country though big players stayed out of this market. E-cigarettes are less harmful than smoking and it makes no sense that the less harmful product is banned when cigarettes are still available.

With the legalization, big multi-national companies are expected to jump into the market with their advertisements as well. For the first time ever, Canadians will see front page newspaper and TV ads about recreational nicotine products. 

USA’s vaping market cannot be described without talking about JUUL. The portable pod kit is dominating the nation with over 70 percent market share. The nicotine salt e-cigarettes have been on the headlines for many reasons. FDA has been investigating JUUL and evaluating their sales and promotion practices. The agency has banned ads of flavors which appeal to the underage market. 

Canada has shifted the regulations in another direction. A bill passed last year changed the way vaping products and other weed products could be advertised. As long as they are not marketed as being ‘healthy’, they can be legally manufactured and sold. They can be advertised as a safer alternative to smoking. Regulations ban the sales to minors, advertising flavors considered appealing to the youth and marketing them as lifestyle products. Fact based advertising can be used to allow adult smokers to decide whether vaping is a better alternative for them to cease smoking. 

The most vape-friendly place in the world, the UK already follows the promotion of vaping as a safer alternative to smoking. Numerous campaigns have helped to educate smokers to benefit from vaping as a smoking cessation tool. Agencies have reviewed UK’s policies regarding the advertisement of vaping products. After consultation with a number of health organizations, vaping products are now made legal for advertisement. 

Advertising that is appealing to the youth, lifestyle in nature, depicting a person or animal will all be prohibited. However, there will be no restrictions about where these ads can appear. Thus, they can appear on radio, TV, bus stops and billboards. Though no flavors are banned in the legislation, labeling and promotion of flavors that appeal to the youth will be banned. 

The advertisements can also not contain health claims though the point of e-cigarettes legalization was to encourage people to move from smoking to less harmful option – vaping. Weed accessories that help users vape better will also be advertised. Companies will not be able to make any health claims at this point, but regulations to this effect are also being worked on.

Can Marijuana Help with Parkinson’s Disease?

Medical Marijuana
Source: Aclu

One of the most debilitating disorders, Parkinson’s causes a lot of motor as well as other problems affecting the patient’s daily life. While there are medicines that can deal with the symptoms, effects are not satisfactory and a lot of people look for more natural options to treat their condition. Recent research has suggested that medical marijuana can prove to be an effective alternative to PD treatments. Let us try to understand how it can help and whether it is really effective for people with Parkinson’s disease.

How Marijuana Affects Brain

Marijuana is a plant species that affect the human brain and body in numerous ways when consumed. The herb was traditionally used for its psychoactive effects on the mind and for spirituality. It was popularly used for recreation and relaxation due to its ability to alter the state of mind. Further investigation showed that the compounds present in the plant bind with chemicals in the brain to alter the way it perceives different sensations. The plant contains more than 100 components that work in different ways in the brain by influencing the receptors to give relief from a variety of conditions.

The Effect on Endocannabinoid System

Every mammal including humans has an endocannabinoid system in the body that contains receptors located in different parts of the body and chemicals that bind to the endocannabinoids. Because of this binding, this system maintains a balance in the body and regulates functions like immune system response, mood, pain perception, appetite and cognition. Science has discovered that components of the cannabis plant can work like chemicals binding with the endocannabinoid receptors in the body to keep the body functioning optimally.

THC and CBD

Cannabidiol and THC are two of the most popular cannabinoids found in the marijuana plant. When ingested, the two compounds influence the cannabinoid receptors in the body to reduce the symptoms of various health conditions and improve overall health and well-being. The body contains a large number of receptors responsible for specific effects. Some of the most known effects of the cannabinoids include nausea, pain, muscle spasms, multiple sclerosis, loss of appetite, glaucoma, Alzheimer’s disease, cancer and more. What makes the two components different is their psychoactive effects. CBD does not cause any mind-altering effects which THC is known for. Both these cannabinoids interact with different receptors in the brain. Medical cannabis may contain THC and cause a high when the person takes the medicine for therapeutic effects. Cannabidiol is capable of counteracting the psychoactive effects of THC.

Medicinal Benefits for Parkinson’s Disease

The naturally occurring components of the cannabis plant are not intended to treat the disease. This is why it should not be expected that it provides an ultimate solution to the symptoms. While more research is still needed to conclude the efficacy of the plant at treating this disorder, current research and studies indicate that THC and CBD are effective at dealing with certain symptoms of Parkinson’s disease like insomnia, pain, stiffness, tremor and weight loss. More clinical studies are required to tell what symptoms can be treated and what doses work for particular symptoms.

Clinical studies performed on patients suffering from psychosis suggested that THC and CBD could reduce the symptoms. Similar results were seen in people with REM behavior sleep disorder. A report also indicates that about half of the patients of Parkinson’s disease using cannabis noted improvement in their symptoms including tremor. While more research is still needed in this area, PD is one of the conditions for which a patient can access medical marijuana in states where it is legally available.

How to Access Medical Marijuana

In recent years, a number of states in America have legalized the use of medical cannabis though there is a difference in the way it is regulated in different states. Some places don’t require a doctor’s recommendation to possess this medicine and adults can easily access it. In some other states, the drug is only available with a practitioner’s prescription. A number of states permit dispensing low THC, high CBD products with a prescription. In the remaining areas, the use of this medicine remains illegal as regulated by the federal government. If you live in one of the states that allow using medical cannabis with a prescription, you can get it at dispensaries and not pharmacies. Only licensed doctors can recommend these products to people suffering from qualifying ailments.